Gossamer Bio, Inc. (GOSS)

Gossamer Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	38.86	32.11	111.97	183.47	486.62	135.09
Short-Term Investments	205.53	264.32	143.71	141.82	26.57	266.74
Cash & Cash Equivalents	244.39	296.43	255.68	325.28	513.19	401.83
Cash Growth	21.07%	15.94%	-21.40%	-36.62%	27.71%	75.58%
Other Current Assets	10.88	10.09	6.2	6.5	9.13	7.49
Total Current Assets	255.27	306.52	261.88	331.78	522.32	409.32
Property, Plant & Equipment	3.48	4.78	9.89	10.8	16.08	15.73
Other Long-Term Assets	0.61	0.62	0.68	1.08	1.03	1.56
Total Long-Term Assets	4.09	5.4	10.57	11.88	17.11	17.29
Total Assets	259.36	311.92	272.45	343.66	539.43	426.6
Accounts Payable	2.66	5.53	1.46	3.24	7.51	0.96
Current Debt	9.59	11.61	11.61	0	0	0
Other Current Liabilities	23.57	34.46	36.16	36.62	31.14	35.97
Total Current Liabilities	35.82	51.6	49.23	39.86	38.65	36.92
Long-Term Debt	196.82	197.55	211.14	182.34	180.1	37.2
Total Long-Term Liabilities	196.82	197.55	211.14	182.34	180.1	37.2
Total Liabilities	232.64	249.15	260.37	222.19	218.75	74.12
Total Debt	206.41	209.16	222.76	182.34	180.1	37.2
Debt Growth	-5.92%	-6.10%	22.17%	1.24%	384.19%	-
Retained Earnings	-1,253.97	-1,212.04	-1,032.22	-811.53	-577.53	-334.17
Comprehensive Income	-0.63	-0.35	-0.57	0.05	0.6	0.26
Shareholders' Equity	26.72	62.77	12.08	121.46	320.68	352.49
Net Cash / Debt	37.99	87.26	32.92	142.95	333.09	364.63
Net Cash / Debt Growth	-	165.06%	-76.97%	-57.09%	-8.65%	59.33%
Net Cash Per Share	0.17	0.57	0.39	1.91	4.86	6.66
Working Capital	219.45	254.92	212.65	291.92	483.67	372.39
Book Value Per Share	0.12	0.41	0.14	1.62	4.68	6.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).